Cargando…

Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis

BACKGROUND: Retinopathy of prematurity (ROP) refers to the developmental disorder of the retina in premature infants and is one of the most serious and most dangerous complications in premature infants. The prevalence of ROP in Iran is different in various parts of Iran and its prevalence is reporte...

Descripción completa

Detalles Bibliográficos
Autores principales: Azami, Milad, Jaafari, Zahra, Rahmati, Shoboo, Farahani, Afsar Dastjani, Badfar, Gholamreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879798/
https://www.ncbi.nlm.nih.gov/pubmed/29606108
http://dx.doi.org/10.1186/s12886-018-0732-3
_version_ 1783311052345180160
author Azami, Milad
Jaafari, Zahra
Rahmati, Shoboo
Farahani, Afsar Dastjani
Badfar, Gholamreza
author_facet Azami, Milad
Jaafari, Zahra
Rahmati, Shoboo
Farahani, Afsar Dastjani
Badfar, Gholamreza
author_sort Azami, Milad
collection PubMed
description BACKGROUND: Retinopathy of prematurity (ROP) refers to the developmental disorder of the retina in premature infants and is one of the most serious and most dangerous complications in premature infants. The prevalence of ROP in Iran is different in various parts of Iran and its prevalence is reported to be 1–70% in different regions. This study aims to determine the prevalence and risk factors of ROP in Iran. METHODS: This review article was conducted based on the preferred reporting items for systematic review and meta-analysis (PRISMA) protocols. To find literature about ROP in Iran, a comprehensive search was done using MeSH keywords in several online databases such as PubMed, Ovid, Science Direct, EMBASE, Web of Science, CINAHL, EBSCO, Magiran, Iranmedex, SID, Medlib, IranDoc, as well as the Google Scholar search engine until May 2017. Comprehensive Meta-analysis Software (CMA) Version 2 was used for data analysis. RESULTS: According to 42 studies including 18,000 premature infants, the prevalence of ROP was reported to be 23.5% (95% CI: 20.4–26.8) in Iran. The prevalence of ROP stages 1, 2, 3, 4 and 5 was 7.9% (95% CI: 5.3–11.5), 9.7% (95% CI: 6.1–15.3), 2.8% (95% CI: 1.6–4.9), 2.9% (95% CI: 1.9–4.5) and 3.6% (95% CI: 2.4–5.2), respectively. The prevalence of ROP in Iranian girls and boys premature infants was 18.3% (95% CI: 12.8–25.4) and 18.9% (95% CI: 11.9–28.5), respectively. The lowest prevalence of ROP was in the West of Iran (12.3% [95% CI: 7.6–19.1]), while the highest prevalence was associated with the Center of Iran (24.9% [95% CI: 21.8–28.4]). The prevalence of ROP is increasing according to the year of study, and this relationship is not significant (p = 0.181). The significant risk factors for ROP were small gestational age (p < 0.001), low birth weight (p < 0.001), septicemia (p = 0.021), respiratory distress syndrome (p = 0.036), intraventricular hemorrhage (p = 0.005), continuous positive pressure ventilation (p = 0.023), saturation above 50% (p = 0.023), apnea (p = 0.002), frequency and duration of blood transfusion, oxygen therapy and phototherapy (p < 0.05), whereas pre-eclampsia decreased the prevalence of ROP (p = 0.014). CONCLUSION: Considering the high prevalence of ROP in Iran, screening and close supervision by experienced ophthalmologists to diagnose and treat the common complications of pre-maturity and prevent visual impairment or blindness is necessary.
format Online
Article
Text
id pubmed-5879798
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58797982018-04-04 Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis Azami, Milad Jaafari, Zahra Rahmati, Shoboo Farahani, Afsar Dastjani Badfar, Gholamreza BMC Ophthalmol Research Article BACKGROUND: Retinopathy of prematurity (ROP) refers to the developmental disorder of the retina in premature infants and is one of the most serious and most dangerous complications in premature infants. The prevalence of ROP in Iran is different in various parts of Iran and its prevalence is reported to be 1–70% in different regions. This study aims to determine the prevalence and risk factors of ROP in Iran. METHODS: This review article was conducted based on the preferred reporting items for systematic review and meta-analysis (PRISMA) protocols. To find literature about ROP in Iran, a comprehensive search was done using MeSH keywords in several online databases such as PubMed, Ovid, Science Direct, EMBASE, Web of Science, CINAHL, EBSCO, Magiran, Iranmedex, SID, Medlib, IranDoc, as well as the Google Scholar search engine until May 2017. Comprehensive Meta-analysis Software (CMA) Version 2 was used for data analysis. RESULTS: According to 42 studies including 18,000 premature infants, the prevalence of ROP was reported to be 23.5% (95% CI: 20.4–26.8) in Iran. The prevalence of ROP stages 1, 2, 3, 4 and 5 was 7.9% (95% CI: 5.3–11.5), 9.7% (95% CI: 6.1–15.3), 2.8% (95% CI: 1.6–4.9), 2.9% (95% CI: 1.9–4.5) and 3.6% (95% CI: 2.4–5.2), respectively. The prevalence of ROP in Iranian girls and boys premature infants was 18.3% (95% CI: 12.8–25.4) and 18.9% (95% CI: 11.9–28.5), respectively. The lowest prevalence of ROP was in the West of Iran (12.3% [95% CI: 7.6–19.1]), while the highest prevalence was associated with the Center of Iran (24.9% [95% CI: 21.8–28.4]). The prevalence of ROP is increasing according to the year of study, and this relationship is not significant (p = 0.181). The significant risk factors for ROP were small gestational age (p < 0.001), low birth weight (p < 0.001), septicemia (p = 0.021), respiratory distress syndrome (p = 0.036), intraventricular hemorrhage (p = 0.005), continuous positive pressure ventilation (p = 0.023), saturation above 50% (p = 0.023), apnea (p = 0.002), frequency and duration of blood transfusion, oxygen therapy and phototherapy (p < 0.05), whereas pre-eclampsia decreased the prevalence of ROP (p = 0.014). CONCLUSION: Considering the high prevalence of ROP in Iran, screening and close supervision by experienced ophthalmologists to diagnose and treat the common complications of pre-maturity and prevent visual impairment or blindness is necessary. BioMed Central 2018-04-02 /pmc/articles/PMC5879798/ /pubmed/29606108 http://dx.doi.org/10.1186/s12886-018-0732-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Azami, Milad
Jaafari, Zahra
Rahmati, Shoboo
Farahani, Afsar Dastjani
Badfar, Gholamreza
Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis
title Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis
title_full Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis
title_fullStr Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis
title_full_unstemmed Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis
title_short Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis
title_sort prevalence and risk factors of retinopathy of prematurity in iran: a systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879798/
https://www.ncbi.nlm.nih.gov/pubmed/29606108
http://dx.doi.org/10.1186/s12886-018-0732-3
work_keys_str_mv AT azamimilad prevalenceandriskfactorsofretinopathyofprematurityiniranasystematicreviewandmetaanalysis
AT jaafarizahra prevalenceandriskfactorsofretinopathyofprematurityiniranasystematicreviewandmetaanalysis
AT rahmatishoboo prevalenceandriskfactorsofretinopathyofprematurityiniranasystematicreviewandmetaanalysis
AT farahaniafsardastjani prevalenceandriskfactorsofretinopathyofprematurityiniranasystematicreviewandmetaanalysis
AT badfargholamreza prevalenceandriskfactorsofretinopathyofprematurityiniranasystematicreviewandmetaanalysis